News | Cardiovascular Ultrasound | January 20, 2017

New Guidelines Discuss Best Practices for 3-D Echocardiography in Congenital Heart Disease

Document outlines technical considerations, imaging techniques and benefits of using 3-D echo in CHD management, including catheter-based interventions

3-D echocardiography, ASE/EACVI guidelines, congenital heart disease, CHD, Journal of the American Society of Echocardiography, JASE

January 20, 2017 — A new document from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE) provides a comprehensive review of the optimal application of 3-D echocardiography for patients with congenital heart disease (CHD).

Congenital heart disease (CHD) is the most common form of birth defect worldwide, affecting 40,000 children born annually in the United States alone. Standard two-dimensional echocardiography, ultrasound of the heart and vascular system, has always been an essential non-invasive diagnostic tool for pediatric cardiologists, but recent advances in technology have led to the increasing importance of three-dimensional echocardiography in this field. 

The paper, “Three-dimensional Echocardiography in Congenital Heart Disease: An Expert Consensus Document from the European Association of Cardiovascular Imaging and the American Society of Echocardiography,” will appear in the January issue of the Journal of the American Society of Echocardiography (JASE), but is available now online

ASE’s co-chair of the writing group, Girish S. Shirali, MBBS, FASE of Children’s Mercy Hospital in Kansas City, Mo., commented, “Pediatric cardiology is unique in the wide range of structural abnormalities that we encounter, and for which echocardiography is the most common — and frequently the only — preoperative diagnostic modality that is used. In the absence of clear guidelines for its use, pediatric cardiac centers from a wide range of geographies have developed a wide range of approaches to 3-D echocardiography. This document helps establish a common logic and structure for the display of images, and uses the collective experience of a large group of echocardiographers and sonographers to help develop a common language and approach to 3-D echocardiography. We believe this modality is a powerful addition to the pediatric echocardiographer's armamentarium, and believe that the current offering will go a long way in enhancing the adoption of 3-D echocardiography for our patients' benefit.”

The document outlines in detail the technical considerations and imaging techniques, as well as the value that 3-D echocardiography can add to the management of specific congenital heart defects. It also details the use of 3-D echocardiography to guide catheter-based interventions, which have become increasingly used in recent years, and addresses the need for specific training and educational pathways specific to 3-D echocardiography. The document includes several useful tables summarizing techniques and advantages of 3-D echocardiography for specific types of CHD, as well as 17 figures to illustrate various concepts.

In conjunction with the publication of the guideline document, Shirali will conduct a live webinar, including a question and answer section, on Feb. 15, 2017 at 5:00 PM Eastern Time. The webinar will be available for free to all ASE members and open to all other clinicians for just $25; registration is available at ASEUniversity.org/ase/live/9. This webinar, and all ASE-hosted guideline webinars, are available on ASEUniversity.org to facilitate education for those who cannot attend the live webcast.

The full guideline document is available on the Journal of American Society of Echocardiography (JASE) website (OnlineJASE.com).  This document and all ASE Guideline documents are also available to the medical community at ASEcho.org/Guidelines.

For more information: www.asecho.org

Related Content

The Smidt Heart Institute at Cedars-Sinai is working with the Keck Medicine of USC heart surgery team to expand care for children and adults with congenital heart disease. An echocardiographer helps with cardiac ultrasound imaging in a hybrid OR during a congenital case using a Siemens SC2000 imaging system. Photo by Cedars-Sinai.

The Smidt Heart Institute at Cedars-Sinai is working with the Keck Medicine of USC heart surgery team to expand care for children and adults with congenital heart disease. An echocardiographer helps with cardiac ultrasound imaging in a hybrid OR during a congenital case using a Siemens SC2000 imaging system. Photo by Cedars-Sinai.

News | Congenital Heart | August 10, 2020
August 10, 2020 - The...
Left, the Melody pulmonary valve was the first transcatheter valve to be approved by the FDA in the United States a decade ago. Right, the Harmony transcatheter valve is in trials and is designed to treat patients with RVOT anomalies who develop severe PR typically when a pervious repair fails. Both valves are used to treat congenital heart defects. #SCAI #SCAI2020

Left, the Melody pulmonary valve was the first transcatheter valve to be approved by the FDA in the United States a decade ago. Right, the Harmony transcatheter valve is in trials and is designed to treat patients with RVOT anomalies who develop severe PR typically when a pervious repair fails. Both valves are used to treat congenital heart defects.

News | Congenital Heart | May 21, 2020
May 21, 2020 — Two late-breaking clinical trials on trans catheter valves to treat congenital heart disease were pres
SCAI Issues Position Statement on Adult Congenital Cardiac Interventional Training, Competencies and Organizational Recommendations. A congenital atrial septal defect closed using a transcatheter occluder, visualized on 3-D TEE ultrasound.

A congenital atrial septal defect closed using a transcatheter occluder, visualized on 3-D TEE ultrasound.

News | Congenital Heart | May 04, 2020
University of Arizona Leads Statewide Study of Congenital Heart Defects
News | Congenital Heart | October 24, 2019
Investigators at the University of Arizona Steele Children's Research Center are leading a statewide study as part of a...
Abbott Receives European CE Mark for Two Pediatric Heart Devices
News | Congenital Heart | September 20, 2019
Abbott announced approvals in Europe for two of its pediatric devices — the Masters HP 15mm rotatable mechanical heart...
High Blood Pressure, Cholesterol in Young Adults Associated With Later Heart Disease
News | Congenital Heart | July 16, 2019
Elevated blood pressure and cholesterol levels in young adulthood may lead to an increased risk of heart disease later...
Hypertension Found in Children Exposed to Flower Pesticides
News | Congenital Heart | June 03, 2019
Researchers at University of California San Diego School of Medicine found higher blood pressure and pesticide...
Edwards Recalls Miller and Fogarty Balloon Dilation Atrioseptostomy Catheters
News | Congenital Heart | April 29, 2019
Edwards Lifesciences is recalling the Miller Balloon Atrioseptostomy Catheter and Fogarty Dilation Atrioseptostomy...
New Pediatric Blood Pressure Guidelines Improve Premature Heart Disease Identification
News | Congenital Heart | April 22, 2019
New guidelines that classified more children as having elevated blood pressure  are better at predicting which kids are...
Better Options Needed for Children at Higher Risk of Premature Heart Disease
News | Congenital Heart | February 28, 2019
Obesity and severe obesity in childhood and adolescence have been added to the list of conditions that put children and...